OptimizeRx (OPRX) Net Margin: 2010-2025
Historic Net Margin for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to 2.99%.
- OptimizeRx's Net Margin rose 458100.0% to 2.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.41%, marking a year-over-year increase of 404400.0%. This contributed to the annual value of 21.83% for FY2024, which is 27300.0% up from last year.
- Per OptimizeRx's latest filing, its Net Margin stood at 2.99% for Q3 2025, which was up 458100.0% from 5.25% recorded in Q2 2025.
- In the past 5 years, OptimizeRx's Net Margin registered a high of 14.6% during Q4 2024, and its lowest value of 49.2% during Q1 2023.
- Over the past 5 years, OptimizeRx's median Net Margin value was 17.54% (recorded in 2023), while the average stood at 16.01%.
- Its Net Margin has fluctuated over the past 5 years, first crashed by -397300bps in 2023, then soared by 559800bps in 2024.
- Quarter analysis of 5 years shows OptimizeRx's Net Margin stood at 3.07% in 2021, then tumbled by -154bps to 1.66% in 2022, then tumbled by -2396bps to 41.38% in 2023, then surged by 135bps to 14.6% in 2024, then crashed by -80bps to 2.99% in 2025.
- Its Net Margin was 2.99% in Q3 2025, compared to 5.25% in Q2 2025 and 10.03% in Q1 2025.